GLP1R and renal fibrosis: Our in silico analyses of public data show a reduction in GLP-1R expression in the kidney samples from mice submitted to UUO (logFC = −3,27 [GSE87212] and logFC = −1,02 [GSE38117]), supporting the use of a GLP-1R agonist as an interesting therapeutic alternative in remodeling of renal fibrosis.